XENETIC BIOSCIENCES, INC. (XBIO) Return on equity 2016–2025
XENETIC BIOSCIENCES, INC. (XBIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-36.2%FY2025 · since FY2016: -335.2% → -36.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -36.2% | +29.7 pp |
| FY2024 | -65.9% | -23.7 pp |
| FY2023 | -42.2% | +5.8 pp |
| FY2022 | -48.0% | -17.3 pp |
| FY2021 | -30.7% | +58.5 pp |
| FY2020 | -89.2% | -15.0 pp |
| FY2019 | -74.2% | -0.6 pp |
| FY2018 | -73.6% | -48.5 pp |
| FY2017 | -25.1% | +310.1 pp |
| FY2016 | -335.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More XBIO financial trends
XBIO RevenueXBIO Net incomeXBIO Net marginXBIO Gross profitXBIO Gross marginXBIO Operating incomeXBIO Operating marginXBIO Operating cash flowXBIO Free cash flowXBIO Capital expendituresXBIO Stock buybacksXBIO Dividends paidXBIO Total assetsXBIO Total liabilitiesXBIO Shareholders’ equityXBIO overview →